Saccharomyces keratitis and endophthalmitis.
Kirsch
L S
LS
Department of Ophthalmology, McGill University, Royal Victoria Hospital, Montreal, Que.
Brownstein
S
S
Deschênes
J
J
Sorgini
C
C
Jackson
W B
WB
D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D000867:Anterior Chamber / Q000382:microbiology; D000935:Antifungal Agents / Q000627:therapeutic use; D003315:Cornea / Q000473:pathology; D009877:Endophthalmitis / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D015821:Eye Infections, Fungal / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D005260:Female; D005437:Flucytosine / Q000627:therapeutic use; D006084:Graft Rejection / Q000382:microbiology / Q000473:pathology; D006801:Humans; D007498:Iris / Q000601:surgery; D007634:Keratitis / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D015948:Keratoplasty, Penetrating; D012008:Recurrence; D012086:Reoperation; D012440:Saccharomyces / Q000302:isolation & purification*; D014821:Vitrectomy; D014822:Vitreous Body / Q000382:microbiology
D000935:Antifungal Agents; D000666:Amphotericin B; D005437:Flucytosine